Cited by 41Estrogen and related hormone effectsNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The role of G protein-coupled estrogen receptor 1 on neurological disorders

Roque, C., Mendes-Oliveira, J., Duarte-Chendo, C., Baltazar, G.·2019·Frontiers in Neuroendocrinology

Abstract

G protein-coupled estrogen receptor 1 (GPER) is a membrane-associated estrogen receptor (ER) associated with rapid estrogen-mediated effects. Over recent years GPER emerged has a potential therapeutic target to induce neuroprotection, avoiding the side effects elicited by the activation of classical ERs. The putative neuroprotection triggered by GPER selective activation was demonstrated in mood disorders, Alzheimer's disease or Parkinson's disease of male and female in vivo rodent models. In others, like ischemic stroke, the results are contradictory and currently there is no consensus on the role played by this receptor. However, it seems clear that sex is a biological variable that may impact the results. The major objective of this review is to provide an overview about the physiological effects of GPER in the brain and its putative contribution in neurodegenerative disorders, discussing the data about the signaling pathways involved, as well as, the diverse effects observed.

Integrity signals

Registry

Crossref · 10.1016/j.yfrne.2019.100786

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PLCD3 is a phospholipase C (PLC) isozyme activated by G protein-coupled estrogen receptor (GPER).

    “Both PLCD3 and SLC22A5 are associated with estrogen‐related signaling pathways (Figure S5), with PLCD3 being a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) 60 , 61 and SLC22A5 being a carnitine transport protein transcriptionally regulated by estrogen receptors. 62”
  • PLCD3 is associated with estrogen-related signaling pathways.

    “Both PLCD3 and SLC22A5 are associated with estrogen‐related signaling pathways (Figure S5), with PLCD3 being a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) 60 , 61 and SLC22A5 being a carnitine transport protein transcriptionally regulated by estrogen receptors. 62”
  • PLCD3 is a phospholipase C (PLC) isozyme activated by G protein-coupled estrogen receptor (GPER) and is involved in phosphoinositide turnover and PKC activation.

    “PLCD3 is a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) and is involved in phosphoinositide turnover and protein kinase C (PKC) activation. 60 , 61”

Cites

1 retracted

Flagged first, then by citations

1 of the 155 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Roque, C., Mendes-Oliveira, J., Duarte-Chendo, C., & Baltazar, G.
Affiliations
University of Beira Interior (PT)
Corresponding author
Baltazar, G.
Venue
Frontiers in Neuroendocrinology
Publisher
Elsevier BV
Published
2019-10
Volume
55
Pages
100786
ISSN
0091-3022 (ISSN-L)
OpenAlex
W2972507530
Cited by
41
References
155
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 15 · 2022: 5 · 2021: 4 · 2020: 6
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • Frontiers in Neuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundação para a Ciência e a Tecnologia (CENTRO-01-0145-FEDER-000013, UID/Multi/00709/2019)
  • Universitat de Barcelona
  • Fundació Catalana de Trasplantament
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
G protein-coupled estrogen receptor, neuroprotection, neurodegenerative diseases, mood disorders, Alzheimer's disease, Parkinson's disease, ischemic stroke, sex differences, estrogen signaling pathway
MeSH terms
Neuroprotection, Autism Spectrum Disorder, Aging, Animals, Female, Humans, Male, Multiple Sclerosis, Parkinson Disease, Receptors, Estrogen, Spinal Cord Injuries, Signal Transduction, Mood Disorders, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review